Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.664 Forscher*innenprofile (davon 1587 mit ORCID-ID), 8.854 Forschungsprojekte, 155.089 Publikationen, Posters und Vorträge, 64.691 Volltextlinks (davon Volltext frei zugänglich: > 28.471 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.999.835, davon 3.913 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 300.307

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Beurteilung der Passgenauigkeit von nicht originalen Abutments bei verschraubten implantatgetragenen Brücken
Projektleitung: Mischitz Ingrida
Laufzeit: 20.10.2025 - 01.02.2027
Geldgeber: Österreichische Gesellschaft für Zahn-, Mund- und Kieferheilkunde Zweigverein Steiermark

Strukturiertes Kommunikationstraining mit standardisierten Patient*innen für die antenatale neonatologische Beratung bei drohender Frühgeburt
Projektleitung: Mileder Lukas Peter
Laufzeit: 01.10.2025 - 31.12.2026
Geldgeber: Österreichische Gesellschaft für Kinder- und Jugendheilkunde

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


29.10.2025:

Graier, T; Lwin, SM; Griffiths, CEM Breaking the Cycle of Psoriasis: The Role for Early Intervention.
Br J Dermatol. 2025; Doi: 10.1093/bjd/ljaf403
PubMed FullText FullText_MUG

 

27.10.2025:

Chua, KJ; Quilang, RC; Sallinger, K; Aktipis, CA; Arck, P; Bianchi, DW; Chang, HD; Cleaves, HJ; Eikmans, M; Fjeldstad, HES; Haig, D; Harrington, WE; Horsnell, W; Jacobsen, DP; Kamper-Jørgensen, M; Kanaan, SB; Khosrotehrani, K; Lambert, NC; Nelson, JL; Olsen, MB; Pan, TD; Prins, JR; Schildberg, FA; Staff, AC; Ståhlberg, A; Stelzer, IA; Urbschat, C; Way, SS; Wilson, MA; Ye, J; Kroneis, T; Boddy, AM Identifying Key Questions and Challenges in Microchimerism Biology.
Adv Sci (Weinh). 2025; e14969 Doi: 10.1002/advs.202514969
PubMed FullText FullText_MUG

 

25.10.2025:

Gompelmann, D; Gysan, MR; Desbordes, P; Maes, J; Van, Orshoven, K; De, Vos, M; Steinwender, M; Helfenstein, E; Marginean, C; Henzi, N; Cerkl, P; Heeb, P; Keusch, S; Calderari, G; von, Boetticher, P; Baumgartner, B; Stolz, D; Simon, M; Prosch, H; Janssens, W; Topalovic, M AI-powered evaluation of lung function for diagnosis of interstitial lung disease.
Thorax. 2025; 80(7):445-450 Doi: 10.1136/thorax-2024-221537 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

24.10.2025:

van, Rens, MFPT; Hugill, K; van, der, Lee, R; Piersigilli, F; Schwaberger, B; Mader, S; van, den, Hoogen, A Enhancing neonatal vascular access: proposing a patient-centered framework based on 7-Rights.
Pediatr Res. 2025; Doi: 10.1038/s41390-025-04521-z
PubMed FullText FullText_MUG

 

23.10.2025:

Vercauteren, J, , EDENT1FI, consortium Harmonising terminology for type 1 diabetes: the EDENT1FI lexicon initiative.
Lancet Diabetes Endocrinol. 2025; 13(11):905-907 Doi: 10.1016/S2213-8587(25)00284-0
PubMed FullText FullText_MUG

 

23.10.2025:

Wurm, S; Moritz, JM; Petzer, V; Wolf, D; Gleixner, KV; Sperr, WR; Groiss, C; Machherndl-Spandl, S; Eisenwort, G; Koller, E; Schoeche, J; Petrasch, C; Singer, J; Mayer, DM; Pregartner, G; Heine, A; Wölfler, A; Sill, H; Reinisch, A; Zebisch, A Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.
Blood Cancer J. 2025; 15(1): 175 Doi: 10.1038/s41408-025-01396-5 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

23.10.2025:

Pilz, S; Schmitt, L; Kraus, DA; Riedmann, U Clinical complexity in osteopenia.
BMJ. 2025; 391: r2154 Doi: 10.1136/bmj.r2154
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz • Impressum